跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 176 条关于
“detrusor”
全部
176
临床试验
160
药物
2
机构
0
资讯
14
8个月前
EG 427's DNA Therapy EG110A Maintains 88% Reduction in Neurogenic Bladder Incontinence at 24 Weeks
去年
EG 427 Secures €27M Series B to Advance Novel Gene Therapy for Spinal Cord Injury-Related Bladder Dysfunction
11个月前
MSN Labs Receives Regulatory Approval for Phase III Trial of Vibegron 75 mg in Overactive Bladder
2个月前
Cyllene Therapeutics Raises €33m Series C to Advance HSV-1 Gene Therapy for Neurogenic Bladder Conditions
16年前
Urovant Sciences Launches GEMTESA® (vibegron) for Overactive Bladder Treatment in the U.S.
去年
Iota Biosciences' Implantable Bladder Device Receives FDA IDE Approval for Clinical Trial
去年
US Court Allows Lupin and Zydus to Expand Patent Defense Arguments in Myrbetriq Generic Drug Case
11个月前
EG 427's HSV Gene Therapy Shows 88% Reduction in Urinary Incontinence Episodes in Phase Ib/IIa Trial
2年前
FDA Accepts Sumitomo Pharma's sNDA for Vibegron in Men with OAB and BPH
去年
Knight Therapeutics Acquires Sumitomo's Canadian Portfolio Including MYFEMBREE and ORGOVYX for C$25.4 Million
第 1 页,共 2 页
上一页
下一页